Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms - Wikidata - awgldk - TriplyDB

Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms

Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms

http://www.wikidata.org/entity/Q28368326

about

Endovascular repair of abdominal aortic aneurysm The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction Periostin links mechanical strain to inflammation in abdominal aortic aneurysm Molecular imaging of matrix metalloproteinase activation to predict murine aneurysm expansion in vivo.Gene expression signature in peripheral blood detects thoracic aortic aneurysm.The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis.Periods of low atmospheric pressure are associated with high abdominal aortic aneurysm rupture rates in Northern Ireland Active smoking increases microsomal PGE2-synthase-1/PGE-receptor-4 axis in human abdominal aortic aneurysms.β-Arrestin-2 deficiency attenuates abdominal aortic aneurysm formation in mice Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation.Recent advances in molecular mechanisms of abdominal aortic aneurysm formation.Inhibition of EP4 signaling attenuates aortic aneurysm formation Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice.Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects.Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation.Matrix metalloproteinases and atherosclerotic plaque instability.The role of matrix metalloproteinases in vascular disease.Prospects for the medical management of abdominal aortic aneurysms.Cardiovascular biology of microsomal prostaglandin E synthase-1.Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm.TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial.Pathogenesis of abdominal aortic aneurysms: role of nicotine and nicotinic acetylcholine receptors.Angiotensin II and abdominal aortic aneurysms.Androgen receptor promotes abdominal aortic aneurysm development via modulating inflammatory interleukin-1α and transforming growth factor-β1 expression.Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.Microvascular COX-2/mPGES-1/EP-4 axis in human abdominal aortic aneurysm.Pharmacological treatment of abdominal aortic aneurysm.Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis.Provocation of experimental aortic inflammation and dilatation by inflammatory mediators and Chlamydia pneumoniae.Mesenchymal stem cells for treatment of aortic aneurysms Indomethacin Prevents the Progression of Thoracic Aortic Aneurysm in Marfan Syndrome Mice.Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.Rapamycin inhibits CaCl2-induced thoracic aortic aneurysm formation in rats through mTOR-mediated suppression of proinflammatory mediators.Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosis.Outcomes of patients undergoing concomitant mitral and aortic valve surgery: results from an Italian regional cardiac surgery registry.Transcriptome sequencing revealed candidate genes relevant to mesenchymal stem cells' role in aortic dissection patients.Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

P2860

Q24201025-1EC723CA-C978-41AE-A391-1DB4E58658F2 Q26741231-12F3E109-914B-452E-8DB7-B71528A96CEA Q27014988-7E83FBC2-CF2B-4008-BDC0-482FDF61E6D6 Q28478432-C7E79280-AE12-4550-919B-299715EB56B5 Q28566851-3C25D3EE-380B-4E31-B8C2-6B72147C2A25 Q30495622-56D63C4B-B594-4B86-97F1-0C15D97FF7BB Q33302909-1F48F99E-602B-4375-8E6C-9B98C8C30AD1 Q33325496-3A8B424E-D92D-4206-8BAC-8F732E450986 Q33434159-0354E94E-043E-4111-B0A9-80F501F9F074 Q33614640-AB15F70D-9E87-484A-919E-DF96364E1E80 Q33985855-07CCCEDC-1C37-4708-AA2D-214DDFB8E3E6 Q34014380-6F36F7DA-2124-4284-A1A0-61ECE6FADE99 Q34081328-FD73C308-2E0F-4193-B7CA-39B86A8ED680 Q34263414-E6719F04-6D3F-4CDC-907E-0783180E427F Q34422563-64BAA48E-E7A0-4FEC-AE0A-088E432C9FAE Q34458717-70ACB700-E7F6-4071-B99B-20C39EBCA006 Q34514569-A8125558-9620-4DA7-94B3-E53ED9C42C31 Q34655385-0AAA6A66-6416-4E5D-B886-331807B6C29E Q34981650-6594D2BB-EE3B-4EDC-A1BB-F6C8400CD6F2 Q35150958-3F220D00-E969-4FFC-8A3D-B6123C1D404D Q35607129-96DA1A3C-666F-4F40-A4D2-A4070D1E705E Q35749972-E3931695-DC99-462E-AFC9-C06341361D22 Q35786928-21A9EA69-996F-4351-BD37-7185D1F84F41 Q35864982-63B8C212-A2F1-459F-B1E0-59B6D17909E2 Q35940023-EAA6632E-41E0-46A7-950C-CDA7F262B7F2 Q36315536-08D7E73B-9119-46DA-A7BE-83BDE29CD486 Q36830815-C7C00E70-402B-465E-8DC1-4E7C1EC46FB0 Q37305427-FB347F0A-41A3-4880-A08C-86AB0BAE84DC Q37489199-E0DEAB2A-5D63-4AE8-ADCB-B7CC33BC6DBF Q37866728-CA20CF42-BAD0-4470-956A-CA1670DF01B0 Q37873916-AFA566FC-9118-4A89-B68F-9AD41AED9BDC Q38234556-EA2AA8E3-A5FA-48A3-8828-4A0EFA7AC7CB Q40074480-67EA6F1A-5380-462A-865A-FC656A17D3A5 Q41062547-EBAF1DAC-68E1-4732-B3E9-4239EA857C76 Q41886163-415607B3-98CF-4932-8E97-7B57358086FC Q42347100-07B7B80C-FDE6-4E13-8847-EA09A657F147 Q42478535-79D64BB3-B05B-4058-B5DE-FC76C3EF65C2 Q44446017-FB18105A-13D2-4260-A94C-33048DB7D95C Q47634824-D25BAE94-2985-44EB-9E01-E8BBB4D690E8 Q47760731-DABDED6B-EDDA-45CD-B839-48F4AC62434A

P2860

Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms

http://www.wikidata.org/entity/Q28368326

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@ast

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@en

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@nl

type

label

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@ast

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@en

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@nl

prefLabel

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@ast

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@en

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@nl

P1433

Q28368326-E0EBC43B-9D1A-48F2-B880-CF6E13EA97E8

P1476

Q28368326-74A2D795-E0BA-47AC-9C63-E1975A239253

P2093

Q28368326-045488CE-C311-4AFB-97DE-D99916B09AB4

Q28368326-2E463AC1-B162-402F-8E9F-C5543C742342

Q28368326-4F756957-8042-40BF-B77E-AE15FC1E3DC9

Q28368326-59A8A8B3-7AE6-46A8-A6F0-321E45AF064B

Q28368326-6A7FEB28-134B-45BE-A7A6-5B8DEA463EED

Q28368326-83A7C4ED-B3DE-422C-B589-8E895DF6FCD5

Q28368326-BF26E6F3-0AA8-46B0-9582-BC7652C913B6

P304

Q28368326-BFD0953F-818A-4D93-9E6F-4511D29C791A

P31

Q28368326-5F92E842-5425-4F21-92CD-B04AD25EBBE9

P3181

Q28368326-0B1A5E7B-39F9-48DE-9D2E-6050D17FDDFB

P356

Q28368326-6B7FB04E-F558-4F47-9863-7BB6862F6748

P407

Q28368326-CD351A6E-FC07-42F4-A25F-637817B24D3B

P433

Q28368326-39EEFC97-00FD-4E31-994F-8FA5AF36BA4E

P478

Q28368326-196AFF36-63AB-472E-8B0E-705927E492AF

P577

Q28368326-53B1B727-4043-4B94-BFE5-7D1435457B8E

P698

Q28368326-5D3FE3BB-177E-4D88-AC8C-A0EB831B4D19

P921

Q28368326-33A1155A-EF80-4BCB-8CFE-CF8A653631D4

P3181

P356

01.CIR.100.1.48

P1433

P1476

Inhibition of prostaglandin E2 ...... of abdominal aortic aneurysms

@en

P2093

G W Taylor

http://www.w3.org/2001/XMLSchema#string

I J Franklin

http://www.w3.org/2001/XMLSchema#string

J T Powell

http://www.w3.org/2001/XMLSchema#string

L C Brown

http://www.w3.org/2001/XMLSchema#string

L J Walton

http://www.w3.org/2001/XMLSchema#string

R M Greenhalgh

http://www.w3.org/2001/XMLSchema#string

T Bayston

http://www.w3.org/2001/XMLSchema#string

P304

48-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3993282

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/01.CIR.100.1.48

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10393680

http://www.w3.org/2001/XMLSchema#string

P921